These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29284789)

  • 21. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D; Thomas-Tikhonenko A
    Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-17~92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways.
    Jin HY; Oda H; Lai M; Skalsky RL; Bethel K; Shepherd J; Kang SG; Liu WH; Sabouri-Ghomi M; Cullen BR; Rajewsky K; Xiao C
    EMBO J; 2013 Aug; 32(17):2377-91. PubMed ID: 23921550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The miR-17∼92 microRNA Cluster Is a Global Regulator of Tumor Metabolism.
    Izreig S; Samborska B; Johnson RM; Sergushichev A; Ma EH; Lussier C; Loginicheva E; Donayo AO; Poffenberger MC; Sagan SM; Vincent EE; Artyomov MN; Duchaine TF; Jones RG
    Cell Rep; 2016 Aug; 16(7):1915-28. PubMed ID: 27498867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma.
    Lollies A; Hartmann S; Schneider M; Bracht T; Weiß AL; Arnolds J; Klein-Hitpass L; Sitek B; Hansmann ML; Küppers R; Weniger MA
    Leukemia; 2018 Jan; 32(1):92-101. PubMed ID: 28659618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers.
    Calado DP; Sasaki Y; Godinho SA; Pellerin A; Köchert K; Sleckman BP; de Alborán IM; Janz M; Rodig S; Rajewsky K
    Nat Immunol; 2012 Nov; 13(11):1092-100. PubMed ID: 23001146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth.
    Hashwah H; Schmid CA; Kasser S; Bertram K; Stelling A; Manz MG; Müller A
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9701-9706. PubMed ID: 28831000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma.
    Zhang J; Vlasevska S; Wells VA; Nataraj S; Holmes AB; Duval R; Meyer SN; Mo T; Basso K; Brindle PK; Hussein S; Dalla-Favera R; Pasqualucci L
    Cancer Discov; 2017 Mar; 7(3):322-337. PubMed ID: 28069569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
    van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW
    Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Critical Role of miR-144 in Diffuse Large B-cell Lymphoma Proliferation and Invasion.
    Wang H; Wang A; Hu Z; Xu X; Liu Z; Wang Z
    Cancer Immunol Res; 2016 Apr; 4(4):337-44. PubMed ID: 26865454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosis.
    Nguyen HV; Vandenberg CJ; Ng AP; Robati MR; Anstee NS; Rimes J; Hawkins ED; Cory S
    Blood; 2020 Mar; 135(13):1019-1031. PubMed ID: 31978211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Premalignant PTEN-deficient thymocytes activate microRNAs miR-146a and miR-146b as a cellular defense against malignant transformation.
    Burger ML; Xue L; Sun Y; Kang C; Winoto A
    Blood; 2014 Jun; 123(26):4089-100. PubMed ID: 24735967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development.
    Tagawa H; Karube K; Tsuzuki S; Ohshima K; Seto M
    Cancer Sci; 2007 Sep; 98(9):1482-90. PubMed ID: 17608773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cooperative STAT/NF-κB signaling regulates lymphoma metabolic reprogramming and aberrant GOT2 expression.
    Feist M; Schwarzfischer P; Heinrich P; Sun X; Kemper J; von Bonin F; Perez-Rubio P; Taruttis F; Rehberg T; Dettmer K; Gronwald W; Reinders J; Engelmann JC; Dudek J; Klapper W; Trümper L; Spang R; Oefner PJ; Kube D
    Nat Commun; 2018 Apr; 9(1):1514. PubMed ID: 29666362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.
    Kelly PN; Grabow S; Delbridge AR; Strasser A; Adams JM
    Blood; 2011 Dec; 118(24):6380-6. PubMed ID: 21998213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas.
    Zappasodi R; Cavanè A; Iorio MV; Tortoreto M; Guarnotta C; Ruggiero G; Piovan C; Magni M; Zaffaroni N; Tagliabue E; Croce CM; Zunino F; Gianni AM; Di Nicola M
    Int J Cancer; 2014 Nov; 135(9):2034-45. PubMed ID: 24648290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-16 induction after CDK4 knockdown is mediated by c-Myc suppression and inhibits cell growth as well as sensitizes nasopharyngeal carcinoma cells to chemotherapy.
    Jiang Q; Zhang Y; Zhao M; Li Q; Chen R; Long X; Fang W; Liu Z
    Tumour Biol; 2016 Feb; 37(2):2425-33. PubMed ID: 26383521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNAs as regulators and mediators of c-MYC function.
    Jackstadt R; Hermeking H
    Biochim Biophys Acta; 2015 May; 1849(5):544-53. PubMed ID: 24727092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of p21 by c-Myc through members of miR-17 family at the post-transcriptional level.
    Wang Z; Liu M; Zhu H; Zhang W; He S; Hu C; Quan L; Bai J; Xu N
    Int J Oncol; 2010 Nov; 37(5):1315-21. PubMed ID: 20878079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Widespread microRNA repression by Myc contributes to tumorigenesis.
    Chang TC; Yu D; Lee YS; Wentzel EA; Arking DE; West KM; Dang CV; Thomas-Tikhonenko A; Mendell JT
    Nat Genet; 2008 Jan; 40(1):43-50. PubMed ID: 18066065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis.
    Sabò A; Kress TR; Pelizzola M; de Pretis S; Gorski MM; Tesi A; Morelli MJ; Bora P; Doni M; Verrecchia A; Tonelli C; Fagà G; Bianchi V; Ronchi A; Low D; Müller H; Guccione E; Campaner S; Amati B
    Nature; 2014 Jul; 511(7510):488-492. PubMed ID: 25043028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.